Welcome to LookChem.com Sign In|Join Free

CAS

  • or

135326-11-3

135326-11-3

Post Buying Request

135326-11-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

  • Gadolinate(2-),[N-[(2S)-2-[bis[(carboxy-kO)methyl]amino-kN]-3-(4-ethoxyphenyl)propyl]-N-[2-[bis[(carboxy-kO)methyl]amino-kN]ethyl]glycinato(5-)-kN,kO]-, hydrogen (1:2), (SA-8-11252634)- 135326-11-3

    Cas No: 135326-11-3

  • No Data

  • 1 Kilogram

  • 10000 Metric Ton/Month

  • Shanghai Upbio Tech Co.,Ltd
  • Contact Supplier

  • Gadolinate(2-),[N-[(2S)-2-[bis[(carboxy-kO)methyl]amino-kN]-3-(4-ethoxyphenyl)propyl]-N-[2-[bis[(carboxy-kO)methyl]amino-kN]ethyl]glycinato(5-)-kN,kO]-, hydrogen (1:2), (SA-8-11252634)-

    Cas No: 135326-11-3

  • No Data

  • 1 Kilogram

  • 1 Metric Ton/Day

  • Shandong Hanjiang Chemical Co., Ltd.
  • Contact Supplier

  • Gadolinate(2-),[N-[(2S)-2-[bis[(carboxy-kO)methyl]amino-kN]-3-(4-ethoxyphenyl)propyl]-N-[2-[bis[(carboxy-kO)methyl]amino-kN]ethyl]glycinato(5-)-kN,kO]-, hydrogen (1:2), (SA-8-11252634)-

    Cas No: 135326-11-3

  • No Data

  • No Data

  • 10000 Metric Ton/Month

  • Henan Wentao Chemical Product Co., Ltd.
  • Contact Supplier

  • Gadolinate(2-),[N-[(2S)-2-[bis[(carboxy-kO)methyl]amino-kN]-3-(4-ethoxyphenyl)propyl]-N-[2-[bis[(carboxy-kO)methyl]amino-kN]ethyl]glycinato(5-)-kN,kO]-, hydrogen (1:2), (SA-8-11252634)-

    Cas No: 135326-11-3

  • USD $ 100.0-100.0 / Gram

  • 10 Gram

  • 500 Kilogram/Month

  • Zibo Hangyu Biotechnology Development Co., Ltd
  • Contact Supplier

135326-11-3 Usage

General Description

Gadoxetic acid, also known as Gd-EOB-DTPA, is a liver-specific magnetic resonance imaging (MRI) contrast agent used to visualize and evaluate liver lesions. It contains the paramagnetic gadolinium ion, which enhances the T1-weighted MRI signals in the liver, allowing for better visualization and characterization of liver tumors and lesions. Gadoxetic acid is taken up by hepatocytes and excreted into the bile, making it particularly useful for differentiating between malignant and benign liver lesions and for evaluating liver function. It is generally well-tolerated, with the most common side effects being mild and transient, such as headache or nausea.

Check Digit Verification of cas no

The CAS Registry Mumber 135326-11-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,3,2 and 6 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 135326-11:
(8*1)+(7*3)+(6*5)+(5*3)+(4*2)+(3*6)+(2*1)+(1*1)=103
103 % 10 = 3
So 135326-11-3 is a valid CAS Registry Number.
InChI:InChI=1/C23H33N3O11.Gd/c1-2-37-18-5-3-16(4-6-18)9-17(26(14-22(33)34)15-23(35)36)10-24(11-19(27)28)7-8-25(12-20(29)30)13-21(31)32;/h3-6,17H,2,7-15H2,1H3,(H,27,28)(H,29,30)(H,31,32)(H,33,34)(H,35,36);/q;+3/p-3/t17-;/m0./s1

135326-11-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Gadoxetic acid

1.2 Other means of identification

Product number -
Other names Gadoxetic

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:135326-11-3 SDS

135326-11-3Upstream product

135326-11-3Downstream Products

135326-11-3Related news

Liver enhancement in healthy dogs after Gadoxetic acid (cas 135326-11-3) administration during dynamic contrast-enhanced magnetic resonance imaging08/19/2019

Dynamic contrast enhanced (DCE)-magnetic resonance imaging (MRI) consists of acquisition of native baseline images, followed by a series of acquisitions performed during and after administration of a contrast medium. DCE-MRI, in conjunction with hepatobiliary-specific contrast media, such as gad...detailed

Relationship between transient severe motion of the liver in Gadoxetic acid (cas 135326-11-3) or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes08/11/2019

PurposeTo clarify the relationship between transient sever motion artifact in arterial phase (TSMA) and changes in peripheral capillary oxygen saturation (SpO2) and heart rate (HR) after contrast media administration during MRI or CT of the liver.detailed

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 135326-11-3